No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina / NY / FL

Medela Announces NEW Pump In Style Breast Pump

Editor: What To Know

  • The Pump In Style Breast Pump with MaxFlow Technology is designed for moms who pump several times a day and need a highly effective breast pump to maintain their supply.
  • , is an exciting milestone for Medela and an opportunity to honor moms with a highly effective, high performing and easy-to-use breast pump that works as hard as they do.
  • A clinical pilot study compared MaxFlow technology with standard breast pump technology, revealing that MaxFlow removes a higher percentage of available milk faster than other breast pumps, a significant benefit for moms seeking to build and maintain their milk supply†.

Medela announced the launch of the NEW Pump In Style with MaxFlow Technology double electric, personal-use breast pump in the U.S. and Canada. Featuring a hospital-performance, a closed system and intuitive control panel, Pump In Style combine the trusted performance moms expect from Medela with exclusive new unique technology and modern design.

“Parents today are busy, and even more so in a COVID-19 quarantined world. They balance jobs, childcare, potential homeschooling, and many other responsibilities, and these hardworking parents deserve a simple product that makes their lives easier,” said Melissa Gonzales, executive vice president of the Americas for Medela. “Redefining the breast pump that has supported millions of moms for nearly 25 years, during National Breastfeeding Month in the U.S., is an exciting milestone for Medela and an opportunity to honor moms with a highly effective, high performing and easy-to-use breast pump that works as hard as they do. During these difficult economic times, we wanted to introduce how we’ve reimagined the #1 breast pump chosen by moms and recommended by doctors** to support the breastfeeding families who need to access a high-quality breast pump through insurance, WIC and our retail partners.”

The Hardworking Pump for the Hardworking Mom

The Pump In Style Breast Pump with MaxFlow Technology is designed for moms who pump several times a day and need a highly effective breast pump to maintain their supply. Whether at home or at the office, running errands or enjoying family time, the NEW Pump In Style combines Medela’s deep knowledge and years of research to deliver hospital performance, an easy-to-use interface, comfort, and reassurance.

  • Performance: Innovative vacuum mechanism combines Medela’s research-based 2-Phase Expression® technology with a NEW MaxFlow technology, generating a vacuum with micro-vibrations to increase and optimize milk flow. A clinical pilot study compared MaxFlow technology with standard breast pump technology, revealing that MaxFlow removes a higher percentage of available milk faster than other breast pumps, a significant benefit for moms seeking to build and maintain their milk supply
  • Easy-to-Use Interface: Intuitive controls allow for simple pump operation and easy experience finding Maximum Comfort Vacuum® level. With fewer parts and large openings, it is also easier to clean compared to the previous version
  • Comfort: Two sizes of PersonalFit Flex™ breast shields with soft rim and oval shape for better fit and effective, yet comfortable pumping. The flex shields are another award-winning innovation added to this pump designed to help mom extract 11.8 percent more milk faster
  • Reassurance: Closed system prevents milk from entering the Y-tubing and pump motor, providing confidence in hygiene and quality of expressed milk. The new tube design eliminates tangling issues and simplifies the connection for double or single pumping

To ensure that all moms have access to continue feeding their babies with breast milk for longer, the new Pump In Style with MaxFlow Technology will be available through insurance plans beginning in September. Medela’s new Pump In Style with Max Flow will be available through major distributors that provide breast pumps through insurance, including Aeroflow Breastpumps, Byram Healthcare, Edgepark, and Medline @ Home; additional breast pump distributors will come online in October and November. Families who qualify for the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) will be able to access Pump In Style with MaxFlow technology in October.

The NEW Pump In Style with MaxFlow Technology retails for U.S. $199.99 to $249.99 SRP. It is available now for U.S. shoppers online at Amazon, Target.com, Walmart.com, BuyBuyBaby.com and in-store at Target, and it will be available in Buy Buy Baby Stores in October and at Walmart in November. For Canadian shoppers, the Pump In Style will be available for purchase beginning August 28 on Amazon.ca, Walmart.ca, BabiesRUs.ca and BuyBuyBaby.com, for $375 CDN.

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy